DENTALKART Vasa Denticity (DENTALKART) Q4 FY26 results (Jan–Mar 2026) and concall
Vasa Denticity reported a total income of ₹283 crores for FY26, with core business growing 33% and a significant increase in new dentists. However, the company faced challenges including a decline in gross margins to 23.7% by Q4 due to own brand stockouts and a weaker rupee, leading to a fall in EBITDA margins from 10% to 4%. The planned IDS Denmed acquisition was abandoned, and management acknowledged past mistakes in supply chain and inventory management, committing to a focus on core business, improved cash flow, and restoring margins.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 0.5%, net profit down 68.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 59 | 63 | 73 | 60 | 73 +22% | 71 +14% | 72 −1% |
| EBITDA | 6 | 6 | 7 | 3 | 6 −5% | 2 −67% | 0 −97% |
| Net profit | 5 | 4 | 4 | 3 | 5 −7% | 2 −61% | 1 −69% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
